venBio Global Strategic GP II, Ltd.

10% owner at Checkmate Pharmaceuticals, Inc.

Sold, on record
$8.5M
Dollars the filings state
Form 4 sales
2
Latest May 4, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Checkmate Pharmaceuticals, Inc.Plan not stated
    Apr 21, 2022 2022

    Sold 547,734 shares at $10.41 ($5.7M)

    venBio Global Strategic GP II, Ltd., 10% owner

    Sold 14.9% of holdings ($38.2M position)3.1M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Checkmate Pharmaceuticals, Inc.Plan not stated
    May 4, 2022 +13 days

    Sold 270,675 shares at $10.38 ($2.8M)

    venBio Global Strategic GP II, Ltd., 10% owner

    Sold 9.6% of holdings ($29.1M position)2.5M shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by venBio Global Strategic GP II, Ltd.
Source
May 4, 2022May 4, 2022Checkmate Pharmaceuticals, Inc.10% ownerForm 4 sale270,675$2.8M9.6%Plan not statedSEC
Apr 21, 2022Apr 21, 2022Checkmate Pharmaceuticals, Inc.10% ownerForm 4 sale547,734$5.7M14.9%Plan not statedSEC